The Check · free · no account needed
Is it too late to buy COHR?
Not an opinion — a read of the evidence. We rank all 2,825 funds that must disclose their trades by how their disclosed buys performed, follow only the specialists, and place every name on the conviction curve: still early, middle innings, or late.
Early, or late? Find out in ten seconds.
Any stock, ETF or fund you own. Free, no account. · Whole 401k? Read your plan →
Specialists — the top-ranked pickers in this exact niche, graded on how their disclosed buys performed. Not generalist whales.
In our receipts, names flagged Fading went a median -5.8% between prints (66% went lower · 29 receipts). The record, not a forecast.
Part of Optical Network Spine — 2 of 4 names now Crowded.
What would change this read:Skilled money re-entering: a fresh specialist buy after the exits.
The last time we flagged a name in this state: APP — −43.6% in the 7 weeks after. № FP-0127 →Watch this name — free — we never delay a warning on your names.
How the read works · The live record vs the S&P 500 · Every past call, timestamped
The evidence base updates this week.
The specialists — not the whales — are already positioned for what comes next. Stop finding out last.
Create your free accountNo card required · open the feed in 30 seconds